Doxakis Anestakis

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Acute Myocardial Infarction

Decision Making

Inflammatory Response

Top Venues

Journal of clinical medicine

International journal of nanomedicine

This page only lists publications with an associated author ORCID identifier.

Publications

Theodora Katopodi, Savvas Petanidis, Eirini Grigoriadou, Doxakis Anestakis, Charalampos Charalampidis, Ioanna P Chatziprodromidou, George Floros, Panagiotis Eskitzis, Pavlos Zarogoulidis, Charilaos Koulouris, Christina Sevva, Konstantinos Papadopoulos, Panagiota Roulia, Stylianos Mantalobas, Marios Dagher, Vasileios Alexandros Karakousis, Nikolaos Varsamis, Konstantinos Vlassopoulos, Vasiliki Theodorou, Chrysi Maria Mystakidou, Nikolaos Iason Katsios, Konstantinos Farmakis, Christoforos Kosmidis
Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy. Pharmaceutics 16 (4) (2024)
Theodora Katopodi, Savvas Petanidis, Eirini Grigoriadou, Doxakis Anestakis, Charalampos Charalampidis, Ioanna P Chatziprodromidou, George Floros, Panagiotis Eskitzis, Pavlos Zarogoulidis, Charilaos Koulouris, Christina Sevva, Konstantinos Papadopoulos, Panagiota Roulia, Stylianos Mantalobas, Marios Dagher, Vasileios Alexandros Karakousis, Nikolaos Varsamis, Konstantinos Vlassopoulos, Vasiliki Theodorou, Chrysi Maria Mystakidou, Nikolaos Iason Katsios, Konstantinos Farmakis, Christoforos Kosmidis
Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy. Pharmaceutics 16 (4) (2024)
Saant Al Mogrampi, Christina Boumpoureka, Hara Afaloniati, Maria K Lagou, Katerina Angelopoulou, Doxakis Anestakis, Zoi Gerasimina Tampouratzi, Stavros Iliadis, Nikolaos Antoniadis, Alexandros Giakoustidis, Apostolos Papalois, Vasileios N Papadopoulos, Theofilos Poutahidis, Dimitrios Giakoustidis
Inhibition of γδ-TcR or IL17a Reduces T-Cell and Neutrophil Infiltration after Ischemia/Reperfusion Injury in Mouse Liver. Journal of clinical medicine 12 (5) (2023)
Theodora Katopodi, Savvas Petanidis, Doxakis Anestakis, Charalampos Charalampidis, Ioanna P Chatziprodromidou, George Floros, Panagiotis Eskitzis, Pavlos Zarogoulidis, Charilaos Koulouris, Christina Sevva, Konstantinos Papadopoulos, Marios Dagher, Nikolaos Varsamis, Vasiliki Theodorou, Chrysi Maria Mystakidou, Nikolaos Iason Katsios, Konstantinos Farmakis, Christoforos Kosmidis
Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery. Pharmaceutics 15 (10) (2023)
Saant Al Mogrampi, Christina Boumpoureka, Hara Afaloniati, Maria K Lagou, Katerina Angelopoulou, Doxakis Anestakis, Zoi Gerasimina Tampouratzi, Stavros Iliadis, Nikolaos Antoniadis, Alexandros Giakoustidis, Apostolos Papalois, Vasileios N Papadopoulos, Theofilos Poutahidis, Dimitrios Giakoustidis
Inhibition of γδ-TcR or IL17a Reduces T-Cell and Neutrophil Infiltration after Ischemia/Reperfusion Injury in Mouse Liver. Journal of clinical medicine 12 (5) (2023)
Drosos Tsavlis, Theodora Katopodi, Doxakis Anestakis, Savvas Petanidis, Charalampos Charalampidis, Evmorfia Chatzifotiou, Panagiotis Eskitzis, Pavlos Zarogoulidis, Konstantinos Porpodis
Molecular and Immune Phenotypic Modifications during Metastatic Dissemination in Lung Carcinogenesis. Cancers 14 (15) (2022)
Kalliopi Domvri, Savvas Petanidis, Paul Zarogoulidis, Doxakis Anestakis, Charalampos Charalampidis, Drosos Tsavlis, Haidong Huang, Lutz Freitag, Wolfgang Hohenforst-Schmidt, Dimitris Matthaios, Theodora Katopodi, Konstantinos Porpodis
Engineered Hybrid Treg-Targeted Nanosomes Restrain Lung Immunosuppression by Inducing Intratumoral CD8 + T Cell Immunity. International journal of nanomedicine 17 (2022)
Eleni Koliakou, Manthou Maria Eleni, Ioanna Koumentakou, Nikolaos D Bikiaris, Polyanthi Konstantinidou, Patricia Rousselle, Doxakis Anestakis, Elisabeth Lazaridou, Evangelia Kalloniati, Dimosthenis Miliaras, Anna Michopoulou
Altered Distribution and Expression of Syndecan-1 and -4 as an Additional Hallmark in Psoriasis. International journal of molecular sciences 23 (12) (2022)